DARPA is offering a grant to develop innovative methods for pausing or slowing down living cells to preserve their viability without cold temperatures. This technology is essential for maintaining and delivering biological therapeutics in the Department of Defense and extending the effectiveness of field forward therapeutics. Refer to document HR001118S0034 for more details. Closing date for applications is May 22, 2018.
Opportunity ID: 301739
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | HR001118S0034 |
| Funding Opportunity Title: | Biostasis |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Other Procurement Contract |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 12.910 — Research and Technology Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 16, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 22, 2018 |
| Current Closing Date for Applications: | May 22, 2018 |
| Archive Date: | Jun 21, 2018 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | DARPA – Biological Technologies Office |
| Description: | DARPA seeks novel approaches to reversibly pause and/or slow the functions and preserve viability of living cells without reliance on cold temperature. This new technology aims to directly address needs within the Department of Defense to maintain and deliver biological therapeutics and extend the window of time for effective use of field forward therapeutics. See the HR001118S0034 document attached. |
| Link to Additional Information: | FBO link |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
DARPA/BTO
ATTN: HR001118S0034 675 North Randolph Street Arlington, VA 22203-2114 Email:Biostasis@darpa.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 301739 Full Announcement-HR001118S0034 -> HR001118S0034.pdf
Folder 301739 Full Announcement-HR001118S0034 -> HR001118S0034_Budget_Template_Biostasis.pdf
Packages
| Agency Contact Information: | DARPA/BTO ATTN: HR001118S0034 675 North Randolph Street Arlington, VA 22203-2114 Email: Biostasis@darpa.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.910 | PKG00239363 | Mar 16, 2018 | May 22, 2018 | View |
Package 1
Mandatory forms
301739 RR_SF424_2_0-2.0.pdf
301739 RR_KeyPersonExpanded_2_0-2.0.pdf
301739 RR_PersonalData_1_2-1.2.pdf
Optional forms
301739 AttachmentForm_1_2-1.2.pdf
301739 RR_OtherProjectInfo_1_4-1.4.pdf
301739 PerformanceSite_2_0-2.0.pdf
301739 SFLLL_1_2-1.2.pdf
301739 Project_Abstract_1_2-1.2.pdf
301739 RR_Budget10_1_4-1.4.pdf
301739 RR_SubawardBudget10_30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
